Atenolol
- Product NDC
- 0615-3532
- 11-digit product format
- 006153532
- Labeler code
- 0615
- Product ID
- 0615-3532_3159bdfa-9386-4eb9-8186-43788920c39c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- atenolol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA073457
- Marketing category
- ANDA
- Marketing start
- 2013-02-18
- Marketing end
- 0000-00-00
- Substance
- ATENOLOL
- Active strength
- 50 mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0615-3532-05 | 2021-03-08 | C162847 | 48780-1 | 9d75b9d0-92ad-f424-e053-dadaa90a57ce | 404b246f-1d29-4a3a-a735-8bf4543984c7 |
| 0615-3532-30 | 2021-03-08 | C162847 | 48780-1 | 9d75b9d0-92ad-f424-e053-dadaa90a57ce | 404b246f-1d29-4a3a-a735-8bf4543984c7 |
| 0615-3532-31 | 2021-03-08 | C162847 | 48780-1 | 9d75b9d0-92ad-f424-e053-dadaa90a57ce | 404b246f-1d29-4a3a-a735-8bf4543984c7 |
| 0615-3532-39 | 2021-03-08 | C162847 | 48780-1 | 9d75b9d0-92ad-f424-e053-dadaa90a57ce | 404b246f-1d29-4a3a-a735-8bf4543984c7 |
| 0615-3532-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-92ad-f424-e053-dadaa90a57ce | 404b246f-1d29-4a3a-a735-8bf4543984c7 |
| 0615-3532-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-92ad-f424-e053-dadaa90a57ce | 404b246f-1d29-4a3a-a735-8bf4543984c7 |
| 0615-3532-31 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-92ad-f424-e053-dadaa90a57ce | 404b246f-1d29-4a3a-a735-8bf4543984c7 |
| 0615-3532-39 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-92ad-f424-e053-dadaa90a57ce | 404b246f-1d29-4a3a-a735-8bf4543984c7 |